Literature DB >> 2894443

The twin impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers.

G W Hallworth1, D G Westmoreland.   

Abstract

The development is described of the twin impinger, a two-stage separation device for assessing the drug delivery from metered dose inhalers and other oral inhalation delivery devices. The discharged aerosol is fractionated by firing through a simulated oropharynx and then through an impinger stage of defined aerodynamic particle size cut-off characteristics. The fine (pulmonary) fraction which penetrates is collected by a lower impinger. It is demonstrated that this device is able to assess individually the fine particle delivery of both components of two-drug aerosols. Formulations showing undue agglomeration or serious crystal growth of drug are readily detected. The twin impinger is shown to be a valuable device for routine quality assessment of aerosols during product development, stability testing and for quality assurance and comparison of commercial products.

Mesh:

Substances:

Year:  1987        PMID: 2894443     DOI: 10.1111/j.2042-7158.1987.tb03142.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  16 in total

1.  Assessment of the twin impinger for size measurement of metered-dose inhaler sprays.

Authors:  N C Miller; V A Marple; R K Schultz; W S Poon
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

2.  Optimized inhalation aerosols. II. Inertial testing methods for particle size analysis of pressurized inhalers.

Authors:  E M Phillips; P R Byron; K Fults; A J Hickey
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

3.  Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive.

Authors:  P Lucas; K Anderson; U J Potter; J N Staniforth
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

4.  Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.

Authors:  P Lucas; K Anderson; J N Staniforth
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

Review 5.  Minimizing variability of cascade impaction measurements in inhalers and nebulizers.

Authors:  Matthew Bonam; David Christopher; David Cipolla; Brent Donovan; David Goodwin; Susan Holmes; Svetlana Lyapustina; Jolyon Mitchell; Steve Nichols; Gunilla Pettersson; Chris Quale; Nagaraja Rao; Dilraj Singh; Terrence Tougas; Mike Van Oort; Bernd Walther; Bruce Wyka
Journal:  AAPS PharmSciTech       Date:  2008-02-28       Impact factor: 3.246

6.  Product lifecycle approach to cascade impaction measurements.

Authors:  Terrence P Tougas; Dave Christopher; Jolyon Mitchell; Svetlana Lyapustina; Michiel Van Oort; Richard Bauer; Volker Glaab
Journal:  AAPS PharmSciTech       Date:  2011-02-01       Impact factor: 3.246

7.  Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers.

Authors:  A Adjei; J Garren
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

Review 8.  Standards for bioequivalence of inhaled products.

Authors:  H Chrystyn
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

9.  A new powder design method to improve inhalation efficiency of pranlukast hydrate dry powder aerosols by surface modification with hydroxypropylmethylcellulose phthalate nanospheres.

Authors:  Y Kawashima; T Serigano; T Hino; H Yamamoto; H Takeuchi
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

10.  Differences in aerodynamic particle size distributions of innovator and generic beclomethasone dipropionate aerosols used with and without a large volume spacer.

Authors:  C J Kenyon; N J Dewsbury; S P Newman
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.